Your browser doesn't support javascript.
loading
Fatal evolution of systemic lupus erythematosus associated with Crohn's disease
Chebli, Júlio M. Fonseca; Gaburri, Pedro Duarte; Souza, Aécio Flávio Meirelles de; Dias, Kátia Valéria Bastos; Cimino, Karla Oliveira; Carvalho-Filho, Roberto José de; Lucca, Fernando de Azevedo.
Affiliation
  • Chebli, Júlio M. Fonseca; Juiz de Fora University. School of Medicine. Juiz de Fora. BR
  • Gaburri, Pedro Duarte; Juiz de Fora University. School of Medicine. Juiz de Fora. BR
  • Souza, Aécio Flávio Meirelles de; Juiz de Fora University. School of Medicine. Juiz de Fora. BR
  • Dias, Kátia Valéria Bastos; Juiz de Fora University. School of Medicine. Department of Medicine. Division of Gastroenterology. Juiz de Fora. BR
  • Cimino, Karla Oliveira; Juiz de Fora University. School of Medicine. Department of Medicine. Division of Gastroenterology. Juiz de Fora. BR
  • Carvalho-Filho, Roberto José de; Juiz de Fora University. School of Medicine. Department of Medicine. Division of Gastroenterology. Juiz de Fora. BR
  • Lucca, Fernando de Azevedo; Juiz de Fora University. School of Medicine. Department of Medicine. Division of Gastroenterology. Juiz de Fora. BR
Arq. gastroenterol ; Arq. gastroenterol;37(4): 224-6, out.-dez. 2000.
Article de En | LILACS | ID: lil-286404
Bibliothèque responsable: BR1.1
RESUMO
Abstract The authors describe the case of a young Brazilian woman who was treated of ileocolonic Crohn's disease sparing rectum, as confirmed by colonoscopy and histopathological examination. After a 4-years course of sulfasalazine treatment, she presented with skin facial lesions in vespertilio, fever, arthralgias and high titers of anti-ANA and LE cells. A sulfasalazine-induced lupus syndrome was diagnosed, because ofter sulfasalazine withdrawal and a short course of prednisone, the clinical symptoms disappeared and the laboratory tests returned to normal. Mesalazine 3 g/day was started and patient remained well for the next 3 years, when she was again admitted with fever, weakness, arthralgias, diplopy, strabismus and hypoaesthesia in both hands and feet, microhematuria, haematic casts, hypocomplementemia and high titers of autoimmune antibodies. A diagnosis of associated systemic lupus erythematosus was made. Although a pulsotherapy with methylprednisolone was started, no improvement was noticed. A cyclophosphamide trial was tried and again no positive results occurred. The patient envolved to severe clinical manifestation of general vasculitis affecting the central and peripheral nervous system and lungs, havaing a fatal evolution after 2 weeks. Although uncommon, the association of both disease may occur, and the authors call attention to this possibiliti, making a brief review of literature.
Sujet(s)
Texte intégral: 1 Indice: LILACS Sujet Principal: Sulfasalazine / Maladie de Crohn / Anti-inflammatoires non stéroïdiens / Mésalazine / Lupus érythémateux disséminé Type d'étude: Risk_factors_studies Limites du sujet: Adult / Female / Humans langue: En Texte intégral: Arq. gastroenterol Thème du journal: GASTROENTEROLOGIA Année: 2000 Type: Article
Texte intégral: 1 Indice: LILACS Sujet Principal: Sulfasalazine / Maladie de Crohn / Anti-inflammatoires non stéroïdiens / Mésalazine / Lupus érythémateux disséminé Type d'étude: Risk_factors_studies Limites du sujet: Adult / Female / Humans langue: En Texte intégral: Arq. gastroenterol Thème du journal: GASTROENTEROLOGIA Année: 2000 Type: Article